Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond (Q34616147)

3 August 2017

1 reference

title

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond (English)

1 reference

3 August 2017

Mohty M

1

1 reference

3 August 2017

publication date

5 April 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

21

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

1387-1394

1 reference

A quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG).

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Detection of renal allograft rejection by complement components C5A and TCC in plasma and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Cell adhesion molecules in clinical renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

The role of adhesion molecules and T cells in ischemic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

T-Cell Function and Migration — Two Sides of the Same Coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

DC-SIGN: escape mechanism for pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

CD25+CD4+ T cells contribute to the control of memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Antigen-induced regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Regulatory T-cell therapy: is it ready for the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Regulatory T cells: prospective for clinical application in hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Suppression of graft-versus-host disease by naturally occurring regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Rabbit antithymocyte globulin versus basiliximab in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Faith supported by reason: mechanistic support for the use of polyclonal antibodies in transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Detection of a novel specificity (CTLA-4) in ATG/TMG globulins and sera from ATG-treated leukemic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

TNF alpha and CD95-L contribute to apoptosis of activated lymphocytes triggered by ATGs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Short course induction immunosuppression with thymoglobulin for renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Short and long-term results after pretransplant high-dose single ATG-fresenius bolus in cadaveric kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Rabbit antithymocyte globulin inhibits monocyte-derived dendritic cells maturation in vitro and polarizes monocyte-derived dendritic cells towards tolerogenic dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Isolation of CD4+CD25+ regulatory T cells for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Protective conditioning for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404683

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404683

1 reference

Dimensions Publication ID

3 August 2017

1045996146

0 references

Fatcat ID

release_jeawctgsnjcknc3ples4owk2fe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jeawctgsnjcknc3ples4owk2fe

24 November 2022

mapped directly with Wikidata item

1 reference